Literature DB >> 9632091

Chloroquine related cardiac toxicity.

J P Veinot1, K T Mai, R Zarychanski.   

Abstract

Chloroquine, an agent used in treatment and prophylaxis of malaria, and also known for its antiinflammatory effects in dermatological, rheumatological, and connective tissue disorders, has been reported to cause toxicity, most commonly in the retina and the cardiovascular system. We describe a 60-year-old woman with longstanding rheumatoid arthritis receiving multidrug treatment, including prolonged administration of chloroquine. She developed complete heart block requiring a permanent pacemaker, congestive heart failure, and progressive myopathy. During hospital investigations for her myopathy, she died of acute pulmonary thromboembolism. Although hypertension and possibly amyloidosis were thought to be the cause of her cardiac disease, cardiac and skeletal muscle changes characteristic of chloroquine toxicity were observed. Chloroquine may be an important unsuspected contributing cause of cardiac dysfunction in patients with rheumatological disease. Endomyocardial biopsy should be considered early in the course of diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632091

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.

Authors:  Janina Preuss; Patrick Maloney; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Palak Gosalia; Monika Milewski; Yujie Linda Li; Eliot Sugarman; Becky Hood; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Eduard Sergienko; Arianna Mangravita-Novo; Michael Vicchiarelli; Danielle McAnally; Layton H Smith; Gregory P Roth; Jena Diwan; Thomas D Y Chung; Esther Jortzik; Stefan Rahlfs; Katja Becker; Anthony B Pinkerton; Lars Bode
Journal:  J Med Chem       Date:  2012-08-06       Impact factor: 7.446

3.  Cardiotoxicity after low-dose chloroquine antimalarial therapy.

Authors:  Gabriele Fragasso; Francesca Sanvito; Francesca Baratto; Sabina Martinenghi; Claudio Doglioni; Alberto Margonato
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

4.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

5.  The prisoner as model organism: malaria research at Stateville Penitentiary.

Authors:  Nathaniel Comfort
Journal:  Stud Hist Philos Biol Biomed Sci       Date:  2009-08-04

Review 6.  The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles.

Authors:  Mauro Toledo Marrelli; Marco Brotto
Journal:  Malar J       Date:  2016-11-02       Impact factor: 2.979

7.  Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis.

Authors:  Meenu Mehta; Parteek Prasher; Mousmee Sharma; Madhur D Shastri; Navneet Khurana; Manish Vyas; Harish Dureja; Gaurav Gupta; Krishnan Anand; Saurabh Satija; Dinesh Kumar Chellappan; Kamal Dua
Journal:  Med Hypotheses       Date:  2020-09-10       Impact factor: 1.538

Review 8.  Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.

Authors:  Emma Kate Zadow; Daniel William Taylor Wundersitz; Diane Louise Hughes; Murray John Adams; Michael Ian Charles Kingsley; Hilary Anne Blacklock; Sam Shi Xuan Wu; Amanda Clare Benson; Frédéric Dutheil; Brett Ashley Gordon
Journal:  Semin Thromb Hemost       Date:  2020-09-03       Impact factor: 4.180

9.  Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.

Authors:  Jason J Kwon; Jeffrey A Willy; Kayla A Quirin; Ronald C Wek; Murray Korc; Xiao-Ming Yin; Janaiah Kota
Journal:  Oncotarget       Date:  2016-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.